Zolpimist Oral Spray, a delivery system of the sleep aid zolpidem tartrate, is now available by prescription. The Zolpimist Oral Spray unit contains 60 metered sprays and provides the flexibility of administering either a 5 or 10 mg dose of the zolpidem active ingredient. As with most prescription hypnotic agents, Zolpimist Oral Spray is federally classified as a CIV controlled substance.
“Zolpimist is a significant addition to ECR, our branded products subsidiary, and reflects our continuing commitment to build this segment of our business through the marketing of widely used, innovative products,” said David Seltzer, president and CEO of Hi-Tech.
Hi-Tech is a specialty pharmaceutical company developing, manufacturing, and marketing generic and branded prescription and OTC products. The company specializes in difficult to manufacture liquid and semisolid dosage forms and produces a range of sterile ophthalmic, otic, and inhalation products. Hi-Tech’s ECR Pharmaceuticals subsidiary markets branded prescription products.
